What is new in the EAS LCN Consensus Statement on harmonisation of lipid clinics

Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death worldwide, responsible for one in three deaths globally. Despite major advances in lipid testing, preventive therapies, and international treatment guidelines, implementation of optimal lipid management remains highly uneven across countries and healthcare systems. Many patients with familial hypercholesterolaemia (FH), elevated lipoprotein(a), severe hypertriglyceridaemia, statin intolerance, and other complex lipid disorders still lack access to specialized care, early diagnosis, and evidence-based treatment.

Why is this paper important?
This consensus paper from the EAS Lipid Clinic Network provides practical recommendations on how lipid clinics can be organised, strengthened, and harmonised across different healthcare settings. It offers guidance on key elements such as education and training, staffing structures, patient pathways, national registries, and healthcare policy. The overall aim is to improve prevention of atherosclerotic cardiovascular disease and other lipid-related disorders, while also supporting more efficient use of healthcare resources.

Within the LCN nationally tailored webinar format, these recommendations can be translated into locally relevant discussions that support implementation in daily clinical practice.

Why now?
The need for coordinated lipid care is increasing rapidly. New diagnostic tools and therapies are continuously emerging, while cardiovascular disease remains a major global health burden. At the same time, the 2024 EAS Lipid Clinic Network survey highlighted significant variation in access to lipid clinics, expertise, and implementation of treatment both between and within countries.

This consensus paper therefore comes at a critical time, providing a framework to support more equitable, effective, and evidence-based lipid care across diverse healthcare systems and regions.

Upcoming webinars

Below you can find the local webinars planned for 2026. Don’t miss the opportunity to register for these tailor-made and insightful sessions.

Georgia


Date: September 16
Time: 18:00-19:00 local time (16:00-17:00 CET)
Language: Georgian/English
Programme:
Chairs: Tea Gamezardashvili

Introduction Tea Gamezardashvili
Why EAS Lipid Clinic Network consensus paper?Borge G. Nordestgaard (Denmark)
Background & lipid clinic types and staffingChristian Bork (Denmark)
Diagnosis & fundingMichal Vrablik (Czech Republic)
Treatment optionsPhilippe Moulin (France)
Education & patient monitoring and follow-upBerit S. Hedegaard (Denmark)
Local perspectiveTBA
Discussion & Q&A

Russia


Date: September 30
Time: 15:00-16:00 local time (14:00-15:00 CET)
Language: Russian/English
Programme:
Chairs: Asiiat Alieva & Marat Ezhov

Introduction Asiiat Alieva & Marat Ezhov
Why EAS Lipid Clinic Network consensus paper?Borge G. Nordestgaard (Denmark)
Background & lipid clinic types and staffingChristian Bork (Denmark)
Diagnosis & fundingMichal Vrablik (Czech Republic)
Treatment optionsPhilippe Moulin (France)
Education & patient monitoring and follow-upBerit S. Hedegaard (Denmark)
Local perspectiveAsiiat Alieva & Marat Ezhov
Discussion & Q&A

Iraq


Date: October 2
Time: 12:00-13:00 local time (11:00-12:00 CET)
Language: English
Programme:
Chairs: Mutaz Al-Sabah

Introduction Mutaz Al-Sabah
Why EAS Lipid Clinic Network consensus paper?Borge G. Nordestgaard (Denmark)
Background & lipid clinic types and staffingChristian Bork (Denmark)
Diagnosis & fundingMichal Vrablik (Czech Republic)
Treatment optionsPhilippe Moulin (France)
Education & patient monitoring and follow-upBerit S. Hedegaard (Denmark)
Local perspectiveKhalid Al-Jumaily
Discussion & Q&A

Brazil


Date: October 21
Time: 12:00-13:00 local time (16:00-17:00 CET)
Language: Portuguese/English
Programme:
Chairs: Sergio Kaiser & Fabiana Rached

Introduction Sergio Kaiser & Fabiana Rached
Why EAS Lipid Clinic Network consensus paper?Borge G. Nordestgaard (Denmark)
Background & lipid clinic types and staffingChristian Bork (Denmark)
Diagnosis & fundingMichal Vrablik (Czech Republic)
Treatment optionsPhilippe Moulin (France)
Education & patient monitoring and follow-upBerit S. Hedegaard (Denmark)
Local perspectiveRaul Santos
Discussion & Q&A

Hungary


Date: November 6
Time: 10:00-11:00 CET
Language: Hungarian/English
Programme:
Chairs: György Paragh & Mariann Harangi

Introduction György Paragh & Mariann Harangi
Why EAS Lipid Clinic Network consensus paper?Borge G. Nordestgaard (Denmark)
Background & lipid clinic types and staffingChristian Bork (Denmark)
Diagnosis & fundingMichal Vrablik (Czech Republic)
Treatment optionsPhilippe Moulin (France)
Education & patient monitoring and follow-upBerit S. Hedegaard (Denmark)
Local perspectiveLászló Márk
Discussion & Q&A

Greece


Date: November 16
Time: 16:00-17:00 local time (15:00-16:00 CET)
Language: Greek/English
Programme:
Chairs: Vasilis Kotsis & Haralampos Milionis

Introduction Vasilis Kotsis & Haralampos Milionis
Why EAS Lipid Clinic Network consensus paper?Borge G. Nordestgaard (Denmark)
Background & lipid clinic types and staffingChristian Bork (Denmark)
Diagnosis & fundingMichal Vrablik (Czech Republic)
Treatment optionsPhilippe Moulin (France)
Education & patient monitoring and follow-upBerit S. Hedegaard (Denmark)
Local perspectiveEvangelos Liberopoulos
Discussion & Q&A

Ukraine


Date: November 19
Time: 11:00-12:00 local time (10:00-11:00 CET)
Language: Ukrainian/English
Programme:
Chairs: Olena Mitchenko

Introduction Olena Mitchenko
Why EAS Lipid Clinic Network consensus paper?Borge G. Nordestgaard (Denmark)
Background & lipid clinic types and staffingChristian Bork (Denmark)
Diagnosis & fundingMichal Vrablik (Czech Republic)
Treatment optionsPhilippe Moulin (France)
Education & patient monitoring and follow-upBerit S. Hedegaard (Denmark)
Local perspectiveTBA
Discussion & Q&A